Do immune-related adverse events correlate with response to immune checkpoint inhibitors?
Author:
Affiliation:
1. Hematology-Oncology Department, Faculty of Medicine, Saint Joseph University of Beirut, Beirut, Lebanon
Publisher
Future Medicine Ltd
Subject
Oncology,Immunology,Immunology and Allergy
Link
https://www.futuremedicine.com/doi/pdf/10.2217/imt-2018-0201
Reference16 articles.
1. Approvals of FDA-regulated products. www.fda.gov/NewsEvents/ProductsApprovals/.
2. Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination
3. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
4. Review: Immune‐Related Adverse Events With Use of Checkpoint Inhibitors for Immunotherapy of Cancer
5. Immune-related adverse events for anti-PD-1 and anti-PD-L1 drugs: systematic review and meta-analysis
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immunosensitivity mediated by downregulated AKT1-SKP2 induces anti-PD-1-associated thyroid immune injury;International Immunopharmacology;2023-08
2. Metabolic patterns on [18F]FDG PET/CT in patients with unresectable stage III NSCLC undergoing chemoradiotherapy ± durvalumab maintenance treatment;European Journal of Nuclear Medicine and Molecular Imaging;2023-03-23
3. Pembrolizumab induced remission of recurrent and metastatic sinonasal squamous cell carcinoma after overcoming checkpoint‐inhibitor pneumonitis: A case report and literature review;Cancer Reports;2023-01-05
4. Understanding the functional inflammatory factors involved in therapeutic response to immune checkpoint inhibitors for pan-cancer;Frontiers in Pharmacology;2022-09-01
5. Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti‐CTLA4 and anti‐PD1 combination immunotherapy: Incidence, management, and clinical benefit;Cancer;2021-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3